Market cap
$98 Mln
Revenue (TTM)
$1 Mln
P/E Ratio
--
P/B Ratio
0
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.6 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
0
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-0
-
Face value
--
-
Shares outstanding
39,161,201
Years Aggregate
CFO
$--
EBITDA
$--
Net Profit
$--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Pharmhouse Corp (PHSE)
| -64.6 | -46.9 | -51.2 | 46.4 | 105.4 | -22.4 | 21.6 |
|
BSE Sensex
| -10.9 | -4.9 | -8.9 | -7.6 | 6.9 | 8.3 | 11.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
|---|---|
|
Pharmhouse Corp (PHSE)
| 1,379.0 |
|
S&P Small-Cap 600
| 4.0 |
|
BSE Sensex
| 9.1 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Pharmhouse Corp (PHSE)
|
0.0 | 97.9 | 1.1 | -2.4 | 0.0 | -- | -- | 0.0 |
| 1.2 | 15.0 | 57.3 | -3.5 | -2.1 | -43.9 | -- | 2.4 | |
| 165.6 | 38,625.7 | 25,612.3 | 83.7 | 5.2 | -- | 107.7 | 136.7 | |
| 6.9 | 87.7 | 77.5 | -21.6 | -10.9 | -- | -- | 27.5 | |
| 353.9 | 8,502.5 | 1,079.0 | -22.3 | -0.9 | -- | -- | 1.6 | |
| 1.5 | 34.3 | -0.1 | -2.6 | 4,101.1 | -6.5 | -- | 0.9 | |
| 0.8 | 26.9 | 0.7 | -2.4 | -346.5 | -145.8 | -- | 15.6 | |
| 125.6 | 18,210.6 | 4,965.5 | 201.5 | 3.2 | 7.6 | 91.3 | 6.7 | |
| 34.7 | 17,886.2 | 7,129.0 | 452.0 | 10.8 | 65.7 | 40.8 | 24.4 | |
| 2.2 | 11.7 | 4.8 | -17.2 | -309.8 | -100.2 | -- | 0.8 |
Shareholding Pattern
View DetailsAbout Pharmhouse Corp (PHSE)
Pride Holdings Group operates as a LGBTQ-focused entertainment, hospitality, and lifestyle company in the United States. It engages in the bar, pub, tavern, restaurant, hotels, nightclubs, and live adult entertainment industry businesses. The company... was formerly known as Parliament House Enterprises, Inc. and changed its name to Pride Holdings Group in July 2025. Pride Holdings Group is based in Orlando, Florida. Address: 2000 N. Orange Ave, Orlando, FL, United States, 32804 Read more
-
CEO & Director
Mr. Ronald M. Herzfeld
-
Chief Executive Officer
Mr. Michael Barrett
-
Headquarters
Orlando, FL
-
Website
FAQs for Pharmhouse Corp (PHSE)
What is the current share price of Pharmhouse Corp (PHSE) Today?
The share price of Pharmhouse Corp (PHSE) is $0.04 (NASDAQ) as of 22-May-2026 15:51 EDT. Pharmhouse Corp (PHSE) has given a return of 105.38% in the last 3 years.
What is the current PB & PE ratio of Pharmhouse Corp (PHSE)?
Since, TTM earnings of Pharmhouse Corp (PHSE) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2024
|
-8.85
|
-6.85
|
|
2023
|
-0.47
|
-4.61
|
|
2022
|
--
|
--
|
|
2021
|
--
|
--
|
|
2020
|
--
|
--
|
What is the 52 Week High and Low of Pharmhouse Corp (PHSE)?
The 52-week high and low of Pharmhouse Corp (PHSE) are Rs 0.20 and Rs 0.01 as of 23-May-2026.
What is the market cap of Pharmhouse Corp (PHSE)?
Pharmhouse Corp (PHSE) has a market capitalisation of $ 98 Mln as on 20-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Pharmhouse Corp (PHSE)?
Before investing in Pharmhouse Corp (PHSE), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.